On ECHEMI
Home > Drugs > Hemorrhagic fever
Hemorrhagic fever
Hemorrhagic fever is an important infectious disease that endangers human health. It is also called hemorrhagic fever with renal syndrome. It is a natural epidemic disease caused by hemorrhagic fever virus. It is widespread, critical, has a high mortality rate, and is extremely harmful. There are 13 types of human viral hemorrhagic fever in the world. According to whether the kidneys are damaged or not, they are divided into two categories: with renal damage and without renal damage. In my country, it is mainly hemorrhagic fever with renal syndrome (HFRS). Before the pathogen was resolved, it was called epidemic hemorrhagic fever (EHF) in my country; Korean hemorrhagic fever (KHF) in North Korea; and hemorrhagic nephropathy nephritis (HNN) in Russia. Due to the establishment of specific serological diagnosis and the solution of etiology, the World Health Organization unified the name of hemorrhagic fever with renal syndrome in 1982. my country still uses the name of epidemic hemorrhagic fever.
Related Drugs
Recombinant human interferon α2a for injection (yeast)
Indication: 1. Treatment of various viral infectious diseases: chronic hepatitis B, hepatitis C, condyloma acuminatum, herpes zoster, influenza and other respiratory viral infections, chronic cervicitis, epidemic hemorrhagic fever, acute hemorrhagic keratitis, chickenpox, etc. 2. Treatment of tumors: multiple myeloma, chronic myeloid leukemia, hairy cell leukemia, non-Hodgkin's lymphoma, malignant melanoma, colorectal cancer, ovarian cancer, hepatocellular carcinoma, bladder cancer, renal cell carcinoma, basal cell carcinoma, etc.
Ligustrazine Hydrochloride Sodium Chloride Injection
Indication: Cardiovascular and cerebrovascular diseases: hypertension, coronary heart disease, unstable angina, ischemic cerebrovascular disease, cerebral infarction, etc. Respiratory system diseases: cor pulmonale, pulmonary hypertension, emphysema, pulmonary fibrosis, chronic respiratory failure, pediatric pneumonia, etc. Others: vertigo, chronic renal failure, epidemic hemorrhagic fever, chronic active hepatitis, cervical spondylosis, sudden deafness, purpuric nephritis.
Manufacturer:

Sichuan Sunnyhope Pharmaceutical Co., Ltd.

Bivalent inactivated vaccine for hemorrhagic fever with renal syndrome (gerbil kidney cells)
Indication: Used to prevent type Ⅰ and type Ⅱ hemorrhagic fever with renal syndrome.
Manufacturer:

Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd.

Sodium Alginate Diester Injection
Indication: It is mainly used for the prevention and treatment of ischemic cerebrovascular diseases such as cerebral thrombosis, cerebral embolism, transient ischemic attack and cardiovascular diseases such as hypertension, hyperlipoproteinemia, coronary heart disease, angina pectoris, etc. It can also be used to treat disseminated intravascular coagulation, chronic glomerulonephritis and hemorrhagic fever.
Manufacturer:

Jiangsu Yabang Qiangsheng Pharmaceutical Co., Ltd.

Sodium Alginate Diester Injection
Indication: It is mainly used for the prevention and treatment of ischemic cerebrovascular diseases such as cerebral thrombosis, cerebral embolism, transient ischemic attack and cardiovascular diseases such as hypertension, hyperlipoproteinemia, coronary heart disease, angina pectoris, etc. It can also be used to treat disseminated intravascular coagulation, chronic glomerulonephritis and hemorrhagic fever.
Sodium Alginate Diester Injection
Indication: It is mainly used for the prevention and treatment of ischemic cerebrovascular diseases such as cerebral thrombosis, cerebral embolism, transient ischemic attack and cardiovascular diseases such as hypertension, hyperlipoproteinemia, coronary heart disease, angina pectoris, etc. It can also be used to treat disseminated intravascular coagulation, chronic glomerulonephritis and hemorrhagic fever.
Manufacturer:

Shandong Yikang Pharmaceutical Co., Ltd.

Sodium Alginate Diester Injection
Indication: It is mainly used for the prevention and treatment of ischemic cerebrovascular diseases such as cerebral thrombosis, cerebral embolism, transient ischemic attack and cardiovascular diseases such as hypertension, hyperlipoproteinemia, coronary heart disease, angina pectoris, etc. It can also be used to treat disseminated intravascular coagulation, chronic glomerulonephritis and hemorrhagic fever.
Manufacturer:

Shanghai Huayuan Pharmaceutical (Ningxia) Shasai Pharmaceutical Co., Ltd.

Sodium Alginate Diester Injection
Indication: It is mainly used for the prevention and treatment of ischemic cerebrovascular diseases such as cerebral thrombosis, cerebral embolism, transient ischemic attack and cardiovascular diseases such as hypertension, hyperlipoproteinemia, coronary heart disease, angina pectoris, etc. It can also be used to treat disseminated intravascular coagulation, chronic glomerulonephritis and hemorrhagic fever.
Manufacturer:

Sinopharm Ronshyn Pharmaceutical Co., Ltd.

Sodium Alginate Diester Injection
Indication: It is mainly used for the prevention and treatment of ischemic cerebrovascular diseases such as cerebral thrombosis, cerebral embolism, transient ischemic attack and cardiovascular diseases such as hypertension, hyperlipoproteinemia, coronary heart disease, angina pectoris, etc. It can also be used to treat disseminated intravascular coagulation, chronic glomerulonephritis and hemorrhagic fever.
Manufacturer:

Zhengzhou Zhuofeng Pharmaceutical Co., Ltd.

Ligustrazine Hydrochloride Sodium Chloride Injection
Indication: Cardiovascular and cerebrovascular diseases: hypertension, coronary heart disease, unstable angina, ischemic cerebrovascular disease, cerebral infarction, etc. Respiratory system diseases: cor pulmonale, pulmonary hypertension, emphysema, pulmonary fibrosis, chronic respiratory failure, pediatric pneumonia, etc. Others: vertigo, chronic renal failure, epidemic hemorrhagic fever, chronic active hepatitis, cervical spondylosis, sudden deafness, purpuric nephritis.
Manufacturer:

Huaren Pharmaceuticals (Rizhao) Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.